Form 4: REGENXBIO CEO Curran Simpson Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
REGENXBIO's CEO, Curran Simpson, sold 9,648 shares of common stock at an average price of $15.04 under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On July 29, 2024, Curran Simpson, the CEO of REGENXBIO Inc., sold 9,648 shares of common stock.
- The sale was executed at a weighted average price of $15.04, with individual transactions ranging from $15.00 to $15.20.
- The transaction was conducted under a Rule 10b5-1 trading plan.
- Following the transaction, Simpson directly owns 170,137 shares of REGENXBIO common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was conducted under a pre-arranged trading plan, suggesting it was not based on any specific positive or negative information about the company.
Industry Context
Sales by insiders are a common occurrence, and the use of a 10b5-1 trading plan allows insiders to sell shares over a period of time without being accused of trading on inside information. The market will often look at the ratio of insider sales to insider buys to determine sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/29/2024 | Date of the stock sale transaction |
| 07/30/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.